Evidence map›Paper›PMID 19241104›Full record

ArticleJournal of the Association for Research in Otolaryngology : JARO2009

Identification of FDA-approved drugs and bioactives that protect hair cells in the zebrafish (Danio rerio) lateral line and mouse (Mus musculus) utricle.

Henry C Ou, Lisa L Cunningham, Shimon P Francis, Carlene S Brandon, Julian A Simon, David W Raible, Edwin W Rubel

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the Association for Research in Otolaryngology : JARO, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 118 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Frontiers in pharmacology · 2024
    Article
  8. Review
  9. Progress in protecting vestibular hair cells.Archives of toxicology · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Cepharanthine: An update of its mode of action, pharmacological properties and medical applications.Phytomedicine : international journal of phytotherapy and phytopharmacology · 2019
    Review
  16. Article
  17. Water Waves to Sound Waves: Using Zebrafish to Explore Hair Cell Biology.Journal of the Association for Research in Otolaryngology : JARO · 2019
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Henry C OuVirginia Merrill Bloedel Hearing Research Center, University of Washington, Box 357923, Seattle, WA 98195, USA. henryou@u.washington.edu
Lisa L Cunningham
Shimon P Francis
Carlene S Brandon
Julian A Simon
David W Raible
Edwin W Rubel
Medical University of South Carolina · USUniversity of Washington · USFred Hutch Cancer Center · US

Funding

UNIVERSITY OF WASHINGTON RESEARCH CORE CENTERP30DC004661 · NIDCD · UNIVERSITY OF WASHINGTON · PI MAX, LUDO, PERKEL, DAVID J · 2000 to 2014
$11.1M
Genetics of Zebrafish Hair Cell ToxicityR01DC005987 · NIDCD · UNIVERSITY OF WASHINGTON · PI RAIBLE, DAVID W · 2003 to 2023
$9.8M
Research Training in OtolaryngologyT32DC000018 · NIDCD · UNIVERSITY OF WASHINGTON · PI STONE, JENNIFER S. · 1989 to 2023
$7.8M
Mechanisms of Sensory Hair Cell Death and SurvivalR01DC007613 · NIDCD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CUNNINGHAM, LISA L · 2005 to 2010
$2.3M
MUSC FACIL EXPANSION &RENOV: SLE C06RR015455 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CROUCH, ROSALIE K · 2002 to 2002
$2.0M
RENOVATION TO SUPPORT SENSORY NEUROSCIENCE RESEARCHC06RR014516 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND, JOHN R · 1999 to 1999
–
NCRR NIH HHS C06 RR014516NCRR NIH HHS C06 RR015455NCRR NIH HHS C06RR015455NCRR NIH HHS C06RR14516NIDCD NIH HHS DC0018NIDCD NIH HHS DC04661NIDCD NIH HHS DC05987NIDCD NIH HHS DC07613NIDCD NIH HHS P30 DC004661NIDCD NIH HHS R01 DC005987NIDCD NIH HHS R01 DC007613NIDCD NIH HHS T32 DC000018
6 · The paper itself

Abstract

The hair cells of the larval zebrafish lateral line provide a useful preparation in which to study hair cell death and to screen for genes and small molecules that modulate hair cell toxicity. We recently reported preliminary results from screening a small-molecule library for compounds that inhibit aminoglycoside-induced hair cell death. To potentially reduce the time required for development of drugs and drug combinations that can be clinically useful, we screened a library of 1,040 FDA-approved drugs and bioactive compounds (NINDS Custom Collection II). Seven compounds that protect against neomycin-induced hair cell death were identified. Four of the seven drugs inhibited aminoglycoside uptake, based on Texas-Red-conjugated gentamicin uptake. The activities of two of the remaining three drugs were evaluated using an in vitro adult mouse utricle preparation. One drug, 9-amino-1,2,3,4-tetrahydroacridine (tacrine) demonstrated conserved protective effects in the mouse utricle. These results demonstrate that the zebrafish lateral line can be used to screen successfully for drugs within a library of FDA-approved drugs and bioactives that inhibit hair cell death in the mammalian inner ear and identify tacrine as a promising protective drug for future studies.

Indexed as

AnimalsAnti-Bacterial AgentsCell SurvivalCholinesterase InhibitorsDose-Response Relationship, DrugDrug Evaluation, PreclinicalHair Cells, AuditoryLateral Line SystemMaleMechanotransduction, CellularMiceNeomycinPharmaceutical PreparationsSaccule and UtricleTacrineUnited StatesAnti-Bacterial AgentsCholinesterase InhibitorsNeomycinPharmaceutical PreparationsTacrine

Identifiers

PMID19241104
PMCPMC2674201
OpenAlexW2169776855

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.